Downregulated Expression of CLEC9A as Novel Biomarkers for Lung Adenocarcinoma

PURPOSE: Abnormal CLEC9A expression is concerned with carcinogenesis. However, the role of CLEC9A in lung adenocarcinoma (LUAD) remains unknown. The goal of this study was to reveal the role of CLEC9A in LUAD based on bioinformatics and cellular functional experiments. MATERIALS AND METHODS: Data av...

Descripción completa

Detalles Bibliográficos
Autores principales: Miao, Fang, Lou, Zhiguo, Ji, Shuhua, Wang, Dan, Sun, Yaolan, Liu, Huan, Yang, Chenggang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489846/
https://www.ncbi.nlm.nih.gov/pubmed/34616670
http://dx.doi.org/10.3389/fonc.2021.682814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489846/
https://www.ncbi.nlm.nih.gov/pubmed/34616670
http://dx.doi.org/10.3389/fonc.2021.682814

Ejemplares similares